NEW YORK (Reuters Health) – After resection of pancreatic adenocarcinoma, chemotherapy with fluorouracil or gemcitabine reduces mortality by about a third, Taiwanese researchers have shown. On the other…
NEW YORK (Reuters Health) – There’s no evidence that starting treatment with the anti-obesity drug orlistat raises the likelihood of developing colorectal cancer, at least in the short…
By Anne Harding NEW YORK (Reuters Health) – Pediatric inflammatory bowel disease (IBD) patients are not at increased mortality risk compared with their IBD-free peers, but they do…
NEW YORK (Reuters Health) – Bevacizumab appears to be most effective for metastatic colorectal cancer when the primary tumor originates distally, according to a Danish study. However, the…
NEW YORK (Reuters Health) – A score based on four factors – low albumin, high bilirubin and α-fetoprotein, and large tumor size – is closely associated with mortality…
By Andrew M. Seaman NEW YORK (Reuters Health) – Low-dose aspirin, even if not taken daily, may reduce a woman’s risk of colon cancer over the long term,…
NEW YORK (Reuters Health) – For patients with head and neck or esophageal cancer undergoing chemoradiotherapy, enteral nutrition enriched with n-3 fatty acids helps preserve body mass. The…
NEW YORK (Reuters Health) – Fidaxomicin, approved by the US Food and Drug Administration in 2011 for the treatment of Clostridium difficile-associated diarrhea, is particularly effective in cancer…
NEW YORK (Reuters Health) – In colorectal cancer patients, ablation of bilateral hepatic metastases with or without surgery compares well to the gold standard approach of bilateral resection,…
NEW YORK (Reuters Health) – Peridural analgesia administered during colorectal cancer resection and postoperatively is associated with improved long-term survival rates, researchers in Germany report. “The present results…